Birk Poller

6PUBLICATIONS
22CO-AUTHORS
Innate immunityToxicology (incl. clinical toxicology)Biomolecular modelling and designCharacterisation of biological macromoleculesPharmacogenomics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jan 08, 2025
Intestinal Cells-on-Chip for Permeability Studies.

Marit Keuper-Navis, Hossein Eslami Amirabadi, Joanne Donkers

|Feb 26, 2024
LTA4H inhibitor LYS006: Clinical PK/PD and safety in a randomized phase I clinical trial.

Christian Loesche, Damien Picard, Benjamin Van Hoorick

|Feb 15, 2024
Improving In Vitro-In Vivo Extrapolation of Clearance Using Rat Liver Microsomes for Highly Plasma Protein-Bound Molecules.

Markus Trunzer, Joana Teigão, Felix Huth

|Jun 12, 2023
Absorption, Distribution, Metabolism, and Excretion of [14C]iptacopan in Healthy Male Volunteers and in In Vivo and In Vitro Studies.

Alexander David James, Kenneth Kulmatycki, Birk Poller

|Oct 04, 2022
Human Pharmacokinetics of LYS006, an Oral Leukotriene A4 Hydrolase Inhibitor Displaying Target-Mediated Drug Disposition.

Birk Poller, David Pearson, Luc Alexis Leuthold

|Feb 26, 2021
Clinical Investigation of Metabolic and Renal Clearance Pathways Contributing to the Elimination of Fevipiprant Using Probenecid as Perpetrator.

H Markus Weiss, Thomas Langenickel, Meredith Cain

Pageof 1